Announcements

Chad Anderson, Executive VP and CFO of Blackbaud Inc, filed a Form 4 on August 18, 2026, disclosing two disposals of common stock tied to tax withholding on the vesting of restricted stock originally granted August 13, 2024.

Fady Ibraham, Executive Vice President of Research and Development at Cytokinetics Inc, filed a Form 4 on August 18, 2026, reporting the exercise of a stock option and the same-day sale of 3,500 shares of common stock under a Rule 10b5-1 plan.

Oliver Ostertag, President, Growth & AI at PAR Technology Corp, filed a Form 4 on August 17, 2026, reporting the sale of 11,829 shares of common stock on August 14, 2026.

Aaron Saltz, Chief Legal Officer of Magnite, Inc. (NASDAQ:MGNI), filed a Form 4 on August 18, 2026, disclosing a non-discretionary disposition of common stock on August 15, 2026, related to the vesting of restricted stock units.

Katie Seitz Evans, President, Product & Operations at Magnite, Inc., filed a Form 4 on August 18, 2026, reporting the forfeiture of 11,204 shares of common stock on August 15, 2026, to cover tax withholding obligations tied to the vesting of restricted stock units.

David Buonasera, Chief Technology Officer of Magnite, Inc., filed a Form 4 on August 18, 2026, reporting a non-discretionary forfeiture of common stock on August 15, 2026, to cover tax withholding obligations tied to the vesting of restricted stock units.

Director Karen L. Zaderej filed a Form 4 with the SEC on August 18, 2026, disclosing an open-market purchase of EyePoint, Inc. common stock on that same date.